Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam.
2002
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Entamoeba histolytica: Genetic Diversity of Clinical Isolates from Bangladesh as Demonstrated by Polymorphisms in the Serine-Rich Gene
2001
Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites
2015 StandoutNobel
Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: Performance and clinical implications in a non-endemic setting
2006
Burden of liver diseases in the world
2018 Standout
Reviews Of Anti‐infective Agents: Anidulafungin: A Novel Echinocandin
2006
Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication
2010
Risk factors associated withHelicobacter pyloriinfection treatment failure in a high prevalence area
2010
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial
1995
Molecular Tracing of the Global Hepatitis C Virus Epidemic Predicts Regional Patterns of Hepatocellular Carcinoma Mortality
2006
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Hepatocellular carcinoma
2012 Standout
Hematological effects of Blastocystis hominis infection in male foreign workers in Taiwan
2003
Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the northern Philippines as detected by the polymerase chain reaction.
1998
Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh.
1999
Anidulafungin: an echinocandin antifungal
2004
Entamoeba histolytica and Entamoeba dispar: Epidemiology and Comparison of Diagnostic Methods in a Setting of Nonendemicity
1999
Therapy for fungal diseases: opportunities and priorities
2010
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Vascular disorders of the liver # †
2008 Standout
Anidulafungin: A new echinocandin with a novel profile
2005
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
Global epidemiology of hepatitis C virus infection
2005 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Global cancer statistics
2011 Standout
The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease
2005
Structure and function of the Entamoeba histolytica Gal/GalNAc lectin
2002
Metronidazole
1997
Toxoplasma gondii Comprises Three Clonal Lineages: Correlation of Parasite Genotype with Human Disease
1995 Standout
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
Giardia lamblia: isoenzyme analysis of 19 axenic strains isolated from symptomatic and asymptomatic patients in Mexico
1989
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
2014
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Management of adult patients with ascites caused by cirrhosis†
1998
Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents
2011
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005
2010
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
High rate of hepatitis C virus infection in an isolated community: Persistent hyperendemicity or period-related phenomena?
1997
Entamoeba histolytica and Entamoeba dispar Infection in Children in Bangladesh
1997
Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt
2002
Amebiasis in HIV-1-Infected Japanese Men: Clinical Features and Response to Therapy
2011
Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies
2003
Antifungal Agents in Children
2005
Amoebiasis
2003 Standout
Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis
2006
Disorders of Iron Metabolism
1999 Standout
Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica.
1992
New antifungal agents under development in children and neonates
2005
Early events in proton pump inhibitor‐associated exacerbation of corpus gastritis
2003
Iron Overload in Africa
1992
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Hepatocellular Carcinoma
2011 Standout
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
Amebiasis and Mucosal IgA Antibody against theEntamoeba histolyticaAdherence Lectin in Bangladeshi Children
2001
Micafungin: A New Echinocandin
2006
Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications
2008
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Recent advances in antifungal chemotherapy
2007
Hepatitis C virus genotypes in two different patient cohorts in Johannesburg, South Africa
2008
Staging and grading of chronic gastritis
2005
RECENT DEVELOPMENTS IN THE EPIDEMIOLOGY OF HELICOBACTER PYLORI
2000
Antiamoebic drugs for treating amoebic colitis
2009
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Metabolism of Entamoeba histolytica Schaudinn, 1903
1985
Entamoeba histolyticaas a Commensal Intestinal Parasite in Homosexual Men
1986
Identification of a Gal/GalNAc Lectin in the Protozoan Hartmannella vermiformis as a Potential Receptor for Attachment and Invasion by the Legionnaires' Disease Bacterium
1997
Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by “Amitochondriate” Protozoan Parasites
2007
Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica.
1994
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
New Insights on Classification, Identification, and Clinical Relevance ofBlastocystisspp
2008 Standout
Trichomoniasis
2004 Standout
Biology ofGiardia lamblia
2001 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Hereditary and nutritional iron overload
1992
Diagnosis of Amebic Liver Abscess and Intestinal Infection with the TechLab Entamoeba histolytica II Antigen Detection and Antibody Tests
2000
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
Cysteine Proteinases and the Pathogenesis of Amebiasis
2000
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica.
1989
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
The prevalence of Helicobacter pylori infection in different countries.
1995
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Analysis of adhesion and cytotoxicity of Tritrichomonas foetus to mammalian cells by use of monoclonal antibodies
1992
A clonal theory of parasitic protozoa: the population structures of Entamoeba, Giardia, Leishmania, Naegleria, Plasmodium, Trichomonas, and Trypanosoma and their medical and taxonomical consequences.
1990
Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar
1997
Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study
2012
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15‐Year Study
2016
Seropositivity for and Intestinal Colonization with Entamoeba histolytica and Entamoeba dispar in Individuals in Northeastern Brazil
1998
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Laboratory Diagnostic Techniques for Entamoeba Species
2007
Echinocandins: role in antifungal therapy, 2005
2005
Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa
2001
Treatment options of invasive fungal infections in adults
2006
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Hidden Killers: Human Fungal Infections
2012 Standout
OLGA Gastritis Staging in Young Adults and Country-Specific Gastric Cancer Risk
2008
Sequential versus standard triple first-line therapy forHelicobacter pylorieradication
2016
Works of A. E. Simjee being referenced
Seroprevalence of Helicobacter pylori infection in Natal/KwaZulu, South Africa
1994
Seroepidemiological study of Helicobacter pylori infection in South African children
1997
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa
2000
Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus
1993
Racial differences in the seroprevalence of hepatitis A virus infection in Natal/KwaZulu, South Africa
1994
Asymptomatic Intestinal Colonization by Pathogenic Entamoeba histolytica in Amebic Liver Abscess: Prevalence, Response to Therapy, and Pathogenic Potential
1992
Association of Serum Antibodies to Adherence Lectin with Invasive Amebiasis and Asymptomatic Infection with Pathogenic Entamoeba histolytica
1990
A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis
2004
Serological differentiation between past and present infection in hepatic amoebiasis
1984
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients
2001
Cell-mediated immunity in hepatic amoebiasis
1985
Hepatitis C virus infection in chronic liver disease in Natal.
1996
SEROEPIDEMIOLOGICAL STUDY OF ANTIBODY RESPONSES TO THE ZYMODEMES OF ENTAMOEBA HISTOLYTICA
1985
Symptoms and investigative findings in 145 patients with tuberculous peritonitis diagnosed by peritoneoscopy and biopsy over a five year period.
1990
A zymodeme study of Entamoeba histolytica in a group of South African schoolchildren
1982
The iron status of Black subjects with amoebiasis.
1984
Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence.
1990
Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay
1990
A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess.
1985
BIOCHEMICAL HOMOGENEITY OF ENTAMOEBA HISTOLYTICA ISOLATES, ESPECIALLY THOSE FROM LIVER ABSCESS
1982
Concomitant and secondary bacterial infection of the pus in hepatic amoebiasis.
1984